O
IMTX icon

OrbiMed’s Immatics IMTX Stock Holding History

OrbiMed’s Portfolio IMTX Stock Details IMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-125,000
Closed -$1.45M – 124
2023
Q3 		$1.45M Buy
+125,000
New +$1.49M 0.03% 117

Other funds holding IMTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OrbiMed's IMTX Position: Q4 2025 in Review

OrbiMed sold out of Immatics (IMTX) in Q4 2025, closing a stake of 466,601 shares — an estimated $3.98M sold.

OrbiMed first reported a position in IMTX in Q1 2023 and held it in 11 quarters. The position peaked at $23.3M in Q2 2024. 75 funds tracked by Wall St. Rank hold IMTX as of Q4 2025.

  • OrbiMed reported no remaining Immatics position as of Q4 2025 after selling out during the quarter.
  • OrbiMed sold 466,601 Immatics shares in Q4 2025, an estimated $3.98M.
  • OrbiMed first reported a position in Immatics in Q1 2023 and held it in 11 quarters.
  • OrbiMed's Immatics position peaked at $23.3M in Q2 2024.
  • 75 funds tracked by Wall St. Rank held Immatics as of Q4 2025.

Based on OrbiMed's 13F filing for Q4 2025, filed 17 Feb 2026.